Emergent Biosolutions, Inc. logo Emergent Biosolutions, Inc. Net Promoter Score 2018 Benchmarks

Estimated Net Promoter Score is

-5

Emergent BioSolutions is a multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases, oncology and autoimmune disorders, and provides medical devices for biodefense purposes.

Among the company's notable products is BioThrax. The company also manufactures pharmaceuticals for adults and children with acute blood disorders, people undergoing certain liver transplants, palliative care for chemo or radiation therapy patients, hemophilia B and a varicella vaccine for high risk patients.

The company has two divisions: a Biodefense division for medical countermeasures and a Biosciences division to treat infectious disease, autoimmune diseases, and cancer.

Fuad El-Hibri, the founder of the company and former CEO, led the company since its founding as BioPort Inc. until his retirement on April 1, 2012. El-Hibri continues to serve as the executive chairman of Emergent BioSolutions’ board of directors.

Quick facts about Emergent Biosolutions, Inc.

Key people Daniel J. Abdun-Nabi (CEO) Fuad El-Hibri (Executive Chairman of the Board of Directors) Daniel J. Abdun-Nabi (President and Chief Executive Officer)
Traded as NYSE: EBS S&P 600 Component
Revenue US $445-$500 million (2014)
Profit US $53-$55 million (2014)
Operating income US $42.8 million (2014)

Net Promoter Score for Top Brands compared with Emergent Biosolutions, Inc.

NPS is a customer loyalty metric that measures customers’ willingness to not only return for another purchase or service but also make a recommendation to their family, friends or colleagues.

It is a powerful and effective technique, which can greatly increase a company's revenue if used properly.

The main advantages of NPS are close correlation with a company's growth and easy collection, interpretation and communication of the data.

Learn more about NPS

Net Promoter Score is a number from -100 from 100.

Scores higher than 0 are typically considered to be good and scores above 50 are considered to be excellent.

The industry average for Health Care / Major Pharmaceuticals is 0.



Browse NPS benchmarks

Customer.guru survey demo

important
How to understand the NPS benchmarks

The final Net Promoter Score of a company strongly depends on a context in which the satisfaction is measured.

Consider an example: If Emergent Biosolutions, Inc. sends out NPS surveys immediately after purchase, they are tracking their customers' initial excitement and the checkout experience.

On the other hand, if they survey their customers a few weeks after the purchase they are also tracking how satisfied their customers are with their products and services over time.

Therefore, comparing the NPS score of Emergent Biosolutions, Inc. with your own without any further context is not that useful.

What is extremely useful though, is using the NPS methodology to track the satisfaction of your customers over time. That's where Customer.guru comes in.

Learn more

Track Segmented Customer Satisfaction with Customer.guru

How are your customers satisfied depending on:

  • what products they purchased
  • when they placed their order
  • what number of orders they made?

    Sign up for free setup takes just 5 minutes

Other companies with Net Promoter Score similar to Emergent Biosolutions, Inc.

We have estimated the Net Promoter Score of Emergent Biosolutions, Inc. based on the publicly available information
including the sentiment of the company-related tweets, 3rd party reviews, and Alexa ratings.

Do you think this information is incorrect? Report incorrect information. Do you have more accurate data? Submit NPS score.